Fund Holdings — Eleva Capital SAS

Total Portfolio Value:
$343.41M
Total Bought:
$343.41M
Total Sold:
$0
Net Transaction:
+$343.41M
Securities
▲▼
SharesValue
Q4 2025
▲▼
Q1 2026
▲▼
Change
▲▼
Q4 2025
▲▼
Q1 2026
▲▼
Weight (%)
▲▼
Change
▲▼
Crh Plc
ORD
02,654,974+2,654,974$0$279.09M81.27%+$279.09M
Amer Sports, Inc.(AS)0298,802+298,802$0$9.84M2.86%+$9.84M
NVIDIA Corporation(NVDA)052,002+52,002$0$9.07M2.64%+$9.07M
Netflix, Inc.(NFLX)087,190+87,190$0$8.38M2.44%+$8.38M
Alphabet Inc.CL A(GOOG)027,967+27,967$0$8.04M2.34%+$8.04M
Taiwan Semiconductor Manufacturing Company LimitedADS(TSM)021,411+21,411$0$6.51M1.89%+$6.51M
Arista Networks, Inc.(ANET)046,957+46,957$0$5.77M1.68%+$5.77M
Amazon.com, Inc.(AMZN)016,155+16,155$0$3.36M0.98%+$3.36M
T-Mobile US, Inc.(TMUS)014,347+14,347$0$3.01M0.88%+$3.01M
Robinhood Markets, Inc.CL A(HOOD)031,625+31,625$0$2.19M0.64%+$2.19M
On Holding AGNAMEN AKT A(ONON)050,150+50,150$0$1.71M0.50%+$1.71M
Boston Scientific Corporation(BSX)026,667+26,667$0$1.67M0.49%+$1.67M
Spotify Technology S.A.SHS(SPOT)02,715+2,715$0$1.32M0.38%+$1.32M
Newamsterdam Pharma Company
ORDINARY SHARES
025,721+25,721$0$823.3K0.24%+$823.3K
CG Oncology, Inc.(CGON)08,289+8,289$0$561.0K0.16%+$561.0K
Esperion Therapeutics Inc0183,047+183,047$0$501.5K0.15%+$501.5K
Mineralys Therapeutics, Inc.(MLYS)017,081+17,081$0$462.7K0.13%+$462.7K
Fennec Pharmaceuticals Inc.(FENC)053,234+53,234$0$327.4K0.10%+$327.4K
Disc Medicine, Inc.(IRON)05,115+5,115$0$327.1K0.10%+$327.1K
Viridian Therapeutics, Inc.(VRDN)07,126+7,126$0$139.4K0.04%+$139.4K
Freeport-McMoRan Inc.CL B(FCX)02,258+2,258$0$132.7K0.04%+$132.7K
Archer Aviation Inc.CL A(ACHR)021,534+21,534$0$111.3K0.03%+$111.3K
Edgewise Therapeutics, Inc.(EWTX)017,460+17,460$0$55.0K0.02%+$55.0K
Aquestive Therapeutics Inc02,720+2,720$0$11.3K0.00%+$11.3K
Page 1 of 1
Eleva Capital SAS — 13F Holdings — Q1 2026 | TickerTrail